J. Goldman & CO LP Abb Vie Inc. Call Options Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $4.64 Million - $5.77 Million	35,000 New	35,000 $4.72 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $6.71 Million - $7.7 Million	50,000 New	50,000 $6.71 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $1 Million - $1.18 Million	-13,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $1.01 Million - $1.25 Million	13,000 New	13,000 $1.2 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.